IMPACT OF COVID-19 ON RADIATION ONCOLOGY IN PAKISTAN

A MASOOD; RMF REHMAN; U QASIM; S ARIF; DV WAKEFIELD; DL SCHWARTZ

doi:10.54112/bcsrj.v2023i1.260

Authors

A MASOOD Department of , Radiation Oncology, Shifa International Hospital Islamabad, Pakistan
RMF REHMAN Department of , Radiation Oncology, Shifa International Hospital Islamabad, Pakistan
U QASIM Department of , Radiation Oncology, Shifa International Hospital Islamabad, Pakistan
S ARIF Department of , Radiation Oncology , Combined Military Hospital Rawalpindi, Pakistan
DV WAKEFIELD Department of , Radiation Oncology , The University of Texas MD Anderson Cancer Center Houston, Texas, United States of America / The University of Tennessee Health Science Center, Memphis, Tennessee, UK
DL SCHWARTZ Department of , Radiation Oncology , The University of Texas MD Anderson Cancer Center Houston, Texas, United States of America / The University of Tennessee Health Science Center, Memphis, Tennessee

DOI:

https://doi.org/10.54112/bcsrj.v2023i1.260

Keywords:

Lockdown, COVID-19, Oncology, Radiation therapy

Abstract

The survey study was conducted in the Radiology Departments of different centers in Pakistan from June 2020 to October 2020 to assess the impact of COVID-19 on radiation therapy in Pakistan. Data about courses in external beam radiography and attendees were extracted from the hospital record. The percentage change in radiotherapy activity for each month between June to October 2020 was calculated and individually compared from June 2019 to October 2019. Results showed that lockdown was significantly associated with a reduction in radiotherapy courses (P<.0001). The mean weekly number of radiotherapy courses decreased by 108 (-19.9%) in June 2020 from 543±170 in June 2019. The largest reduction in radiotherapy courses after the lockdown was reported in non-melanoma skin cancer and prostate cancer. Data analysis showed that radiation therapy services fell significantly at the onset of COVID-19. Cancers whose treatment can be safely delayed were most affected. On the other hand, cancers in which radiotherapy offered an alternative to surgery had seen a rise in treatment courses.

Downloads

Download data is not yet available.

References

Al-Quteimat, O. M., and Amer, A. M. (2020). The impact of the COVID-19 pandemic on cancer patients. American journal of clinical oncology.

Guidance, N. (2020). COVID-19 rapid guideline: delivery of radiotherapy.

Hanif, M., Haider, M. A., Ali, M. J., Naz, S., and Sundas, F. (2020). Reinfection of COVID-19 in Pakistan: a first case report. Cureus 12.

Kunkler, I. H., Williams, L. J., Jack, W. J., Cameron, D. A., and Dixon, J. M. (2015). Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial. The lancet oncology 16, 266-273.

Lai, A. G., Pasea, L., Banerjee, A., Denaxas, S., Katsoulis, M., Chang, W. H., Williams, B., Pillay, D., Noursadeghi, M., and Linch, D. (2020). Estimating excess mortality in people with cancer and multimorbidity in the COVID-19 emergency. MedRxiv, 2020.05. 27.20083287.

Martinez, D., Sarria, G. J., Wakefield, D., Flores, C., Malhotra, S., Li, B., Ehmann, M., Schwartz, D. L., and Sarria, G. R. (2020). COVID’s impact on radiation oncology: a Latin American survey study. Vol. 108, pp. 374-378. Elsevier.

Oncology, A. S. f. R. (2020). COVID-19′ s impact on radiation oncology. Initial Results of a Nationwide Physician Survey. Available online: https://www. astro. org/ASTRO/media/ASTRO/News% 20and% 20Publications/PDFs/ASTROCOVID19Survey1-ExecSummary. pdf (accessed on 30 June 2021).

Slotman, B. J., Lievens, Y., Poortmans, P., Cremades, V., Eichler, T., Wakefield, D. V., and Ricardi, U. (2020). Effect of COVID-19 pandemic on practice in European radiation oncology centers. Radiotherapy and Oncology 150, 40-42.

Spencer, K., Jones, C. M., Girdler, R., Roe, C., Sharpe, M., Lawton, S., Miller, L., Lewis, P., Evans, M., and Sebag-Montefiore, D. (2021). The impact of the COVID-19 pandemic on radiotherapy services in England, UK: a population-based study. The lancet oncology 22, 309-320.

Sud, A., Jones, M. E., Broggio, J., Loveday, C., Torr, B., Garrett, A., Nicol, D. L., Jhanji, S., Boyce, S. A., and Gronthoud, F. (2020). Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic. Annals of Oncology 31, 1065-1074.

Wakefield, D. V., Sanders, T., Wilson, E., Hubler, A., DeWeese, T., Smith, B. D., Slotman, B. J., Sarria, G. R., Eichler, T., and Schwartz, D. L. (2020). Initial impact and operational responses to the COVID-19 pandemic by American Radiation Oncology Practices. Vol. 108, pp. 356-361. Elsevier.

Waris, A., Atta, U., Ali, M., Asmat, A., and Baset, A. (2020). COVID-19 outbreak: current scenario of Pakistan. New microbes and new infections 35, 100681.

Williamson, E. J., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., and Inglesby, P. (2020). Factors associated with COVID-19-related death using OpenSAFELY. Nature 584, 430-436.

Xing, T., Hettige, S., Chee, L. Y. S., Nair, R., Hegde Sr, R., Xing, D., and Hegde, R. (2021). Curative radiotherapy for locally advanced scalp squamous cell carcinoma. Cureus Journal of Medical Science 13.

Yu, J., Ouyang, W., Chua, M. L., and Xie, C. (2020). SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China. JAMA oncology 6, 1108-1110.